Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis. Revista Alergia México, [S. l.], v. 65, n. 2, p. 192–196, 2018. DOI: 10.29262/ram.v65i2.292. Disponível em: https://ojs.revistaalergia.mx/ojs/index.php/ram/article/view/292. Acesso em: 24 sep. 2026.